ADB-BUTINACA

**ADB-BUTINACA**
法律規範狀態
法律規範	加：Schedule II; 德：NpSG; 英：Class B; 美：附表I;
识别信息
	IUPAC命名法 N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide; ;
CAS号	2682867-55-4
PubChem CID	155907792;
ChemSpider	81407832;
UNII	ZJ6LS4NVM9;
ChEMBL	ChEMBL5169682;
化学信息
化学式	C18H26N4O2
摩尔质量	330.43 g·mol−1
3D模型（JSmol（英语：JSmol））	交互式图像;
	SMILES O=C(N[C@H](C(N)=O)C(C)(C)C)C1=NN(CCCC)C2=C1C=CC=C2;
	InChI InChI=1S/C18H26N4O2/c1-5-6-11-22-13-10-8-7-9-12(13)14(21-22)17(24)20-15(16(19)23)18(2,3)4/h7-10,15H,5-6,11H2,1-4H3,(H2,19,23)(H,20,24)/t15-/m1/s1; Key:GPWADXHYJAZPAX-OAHLLOKOSA-N;

参考文献

^ Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-15]. （原始内容存档于2023-08-03）（巴西葡萄牙语）.
^ Kavanagh P, Pechnikov A, Nikolaev I, Dowling G, Kolosova M, Grigoryev A. Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver. Journal of Analytical Toxicology. July 2022, 46 (6): 641–650. PMID 34341821. doi:10.1093/jat/bkab088.
^ Sia CH, Wang Z, Goh EM, Tan YL, Fong CY, Moy HY, Chan EC. Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse. Clinical Chemistry. November 2021, 67 (11): 1534–1544. PMID 34387654. doi:10.1093/clinchem/hvab134 .